According to filings with the U.S. Securities and Exchange Commission, Rimidi is raising up to $5,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Lucienne Ide played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Rimidi
Created by doctors, Rimidis leading clinical management platform empowers healthcare organizations to optimize clinical workflows, enhance patient experiences and achieve quality objectives. By bringing together clinical decision support, remote patient monitoring and patient reported outcomes in a unified, composable, FHIR-based platform, Rimidi supports a broad range of clinical use cases across healthcare organizations, including diabetes, heart failure, cardiovascular disease, fatty liver disease, respiratory diseases, and obesity. Our Core Values: Tenacity: We believe that healthcare can and should be better, and that our work makes an impact. Curiosity: We set out to solve problems big or small. We strive to find new ways to think, and new ways to do things. Collaboration: Our clients are at the center of everything we do, and we rely on their feedback and partnership to continuously innovate and improve. Dependability: We mean what we say, and we do what we say. We deliver on our promises. Diversity: We value the diverse thoughts and lived experiences of the people behind our mission. .

To learn more about Rimidi, visit http://rimidi.com/

Contact:
Lucienne Ide, President and Chief Executive Officer
404-317-4400
https://www.linkedin.com/in/lucienneide/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.